The fear of another stroke has always been the sword of Damocles in many stroke patients. A study has shown that taking the antiplatelet cilostazol can reduce the incidence of stroke among high-risk patients, especially those who already suffered from it before.
The Cilostazol Stroke Prevention Study (CSPS) was a double-blind and placebo-controlled trial done in Japan involving more than 1,000 patients who had a previous stroke.
It investigated the preventive effects of cilostazol on the recurrence of cerebral infarction (stroke) and it showed a 41.7 percent risk reduction of secondary stroke events with cilostazol compared to placebo.
Stroke is also known as brain attack. It happens when the vital supply of blood and oxygen is cut off to a part of the brain. (more…)
October 26th, 2008
Von
Posted in
Tags:




